Eli Lilly announced a partnership with Walmart on Wednesday to expand access to its GLP-1 Zepbound through LillyDirect, marking LillyDirect’s first retail collaboration. LillyDirect is Eli Lilly’s ...
HHS proposed changes that would roll back many Biden-era policies, eliminate most health tech certification criteria,and ...
Morgan Health made a $25 million investment in Merative, a data, analytics and technology provider, the companies announced Tuesday. Washington, D.C.-based Morgan Health is a JPMorgan Chase business ...
Peptide drugs, such as the metabolic medicines Mounjaro and Zepbound from Eli Lilly, must be administered as injections. But the biotech industry has been pursuing ways to make peptides into pills, ...
We are only two weeks into 2025, and a small handful of healthcare AI companies have already announced funding rounds exceeding $100 million — signaling a strong start to what investors predicted ...
Like most industries, healthcare is experiencing financial pressure and unprecedented AI advancements. Organizations are also grappling with a political and economic environment that is more dynamic ...
Across the healthcare industry, patients are demanding more transparency. They want control over their health and access to their healthcare data. And they’re right – patients should be at the center ...
Schizophrenia is currently treated with older medications with limited efficacy and troublesome side effects that lead many patients to stop taking them. The FDA has approved a novel Bristol Myers ...
An experimental GLP-1 obesity drug from Terns Pharmaceuticals led to a 5.5% reduction in body weight in a small study, continuing to build its case as a potential oral alternative to currently ...
Wearable technology that measures people’s physiological data has gotten quite small over the past decade — with some devices now the size of a mere ring or a watch. That’s not an unequivocally good ...
More than 50 major insurers have pledged to streamline prior authorization starting in 2026, but providers remain cautiously optimistic and skeptical that the changes will truly reduce burden or ...
The use of AI in healthcare is rapidly growing, but physicians are often left out of the conversation about how these technologies should be implemented effectively. That’s why the American Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results